The human body’s metabolism acts as a metabolic engine that operates around the clock, converting nutrients into the energy needed for every cellular function. This complex biochemical process ...
The novel investigational weight loss agent HU6 had mixed results specifically targeting obesity-related heart failure with preserved ejection fraction (HFpEF), based on the small HuMain-HFpEF trial.
Please provide your email address to receive an email when new articles are posted on . HU6, a controlled metabolic accelerator, conferred significant weight loss in patients with obesity-related ...
Please provide your email address to receive an email when new articles are posted on . HU6, a novel controlled metabolic accelerator, reduced weight at 3 months vs. baseline and vs. placebo in ...
CHARLOTTESVILLE, Va. and SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Rivus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company dedicated to treating obesity and ...
– New data from the HuMAIN study, which met the primary endpoint of weight loss and several efficacy and pharmacodynamic secondary endpoints, will be presented in a Late Breaking Clinical Research ...
A metabolic reset is not a scientific procedure. Instead, it involves various lifestyle and dietary changes that aim to improve a person’s metabolic health and potentially lose body weight. Weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results